Merging our Strengths: Vesper Medical acquired by Philips to expand its therapeutic devices portfolio Read More

Advancing and improving the treatment of deep venous disease

Vesper Medical is a privately held company shaping the future of treating deep venous disease through the creation of a next-generation, modular, and uniquely engineered venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins and provides the ability to customize therapy to a broad range of patient needs.

Vesper Medical’s leadership team is comprised of professionals who share a passion and commitment to advancing the treatment of deep venous disease.

Management Team

Bruce J. Shook

President and CEO

Joseph C. Griffin, III

Vice President, Regulatory Affairs and Quality Assurance, Compliance Officer

Mike Longo

Vice President of Research and Development

Marc Penna

Vice President, Clinical Affairs

Monica L. Klos


Suzanne Wallace, CRNP

Senior Director, Clinical Marketing

Andrea Dunkle

Director, Human Resources and Administration

Board of Directors

Bruce J. Shook

President and CEO, Vesper Medical

Justin Klein, MD, JD

Managing Partner, Vensana Capital

Geoff Pardo

Partner, Gilde Healthcare

Mark Garcia, MD

Co-founder & Medical Director
Vascular & Interventional Associates of Delaware

Tak Cheung

General Partner, New Enterprise Associates

Neil Hattangadi, MD

CEO, Cortica
Former Business Leader, Peripheral Vascular, Phillips

Stacy Enxing Seng

Venture Partner, Lightstone Ventures

Scientific Advisory Board

Peter Neglen, MD


Paul Gagne, MD

Southern Connecticut Vascular Center, Darien, CT

Stephen Black, MD

Guy's and St. Thomas' NHS Foundation Trust, London, UK

Rick De Graff, MD

Maastricht U., Maastricht, NL

Michael Lichtenberg, MD

Klinikum Arnsberg, Arnsberg, Germany

Gerry O'Sullivan, MD

Galway U., Galway, Ireland

Thomas Zeller, MD

Universitaet-Herzzentrum, Bad Krozingen, Germany

Marianne Brodmann, MD

Medical U. Graz, Graz, Austria

Mike Dake, MD

Stanford U., Stanford, CA

Mahmood Razavi, MD

Vascular & Interventional Specialists of Orange Country, Orange, CA

Raghu Kolluri, MD

Ohio Health Heart and Vascular, Columbus, OH

Deepak Sudheendra, MD

University of Pennsylvania, PA

Erin Murphy, MD

Sanger Heart & Vascular Institute, Charlotte, NC

Patty Thorpe, MD

Arizona Heart Hospital, Phoenix, AZ

John Rundback, MD

Holy Name Medical Center, Teaneck, NJ

Kathleen Gibson, MD

Lake Washington Vascular, Bellevue, WA


Vesper Medical enjoys the support of some of the most experienced and accomplished investors in the medical device industry, including New Enterprise Associates (NEA), Gilde Healthcare, Vensana Capital and Quaker Partners.

Vision, Mission, Values

Our vision is a world that is free from the pain and disability that is associated with deep venous disease. We are dedicated to improving life for patients suffering from deep venous disease and developing technology for the physicians who treat them. Our core values are respect, integrity, innovation, quality, and above all patients first.

Vesper Medical Logo

Contact us for information about Vesper Medical and the VIVID clinical study

* Required Field

Scroll to Top